Animal models for drug discovery in dystonia
- 19 December 2007
- journal article
- review article
- Published by Taylor & Francis in Expert Opinion on Drug Discovery
- Vol. 3 (1) , 83-97
- https://doi.org/10.1517/17460441.3.1.83
Abstract
(2008). Animal models for drug discovery in dystonia. Expert Opinion on Drug Discovery: Vol. 3, No. 1, pp. 83-97.Keywords
This publication has 69 references indexed in Scilit:
- Treatment of dystoniaThe Lancet Neurology, 2006
- A systematic review on the diagnosis and treatment of primary (idiopathic) dystonia and dystonia plus syndromes: report of an EFNS/MDS‐ES Task ForceEuropean Journal of Neurology, 2006
- Loss of the Dystonia-Associated Protein TorsinA Selectively Disrupts the Neuronal Nuclear EnvelopeNeuron, 2005
- Impaired Motor Learning in Mice Expressing TorsinA with the DYT1 Dystonia MutationJournal of Neuroscience, 2005
- Rodent models for dystonia research: Characteristics, evaluation, and utilityMovement Disorders, 2005
- Intrathecal baclofen for generalized dystoniaDevelopmental Medicine and Child Neurology, 2001
- Dystonia and parkinsonismParkinsonism & Related Disorders, 2001
- Mutant torsinA, responsible for early-onset torsion dystonia, forms membrane inclusions in cultured neural cellsHuman Molecular Genetics, 2000
- Baclofen in the Treatment of DystoniaClinical Neuropharmacology, 1992
- DYSKINETIC CEREBRAL PALSYActa Paediatrica, 1982